Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NNC 0756

Known as: NNC 756, NNC-0756, NNC-756 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
The full efficacy, high potency isochroman D-1 agonist A 68930 demonstrated greater than 220-fold selectivity for D-1 over D-2… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2005
2005
In order to relate the effects of pharmacological intervention to neuroleptic induced increases in oral activity rats were… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
1998
Highly Cited
1998
NNC 756 ((+)-8-chloro-5-(2,3-dihydrobenzofuran-7-yl)-7-hydroxy-3-methyl-2,3,4,5- tetrahydro-1H-3-benzazepine) is a new high… Expand
Is this relevant?
Highly Cited
1993
Highly Cited
1993
A series of antipsychotics having different selectivity for dopamine (DA) D-1 and D-2 receptors were studied for their effects on… Expand
Is this relevant?
1993
1993
When given subcutaneously in gradually increasing doses, up to 1 mg/kg, NNC 756, a dopamine (DA) D-1 antagonist, failed to… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
1993
1993
Rats were treated intermittently or continuously with the dopamine D1 receptor antagonist NNC-756 for 15 weeks. Two weeks after… Expand
Is this relevant?
Highly Cited
1992
Highly Cited
1992
The neurochemical properties of three novel benzazepine derivatives NNC-112, NNC-687 and NNC-756 were assessed. These compounds… Expand
Is this relevant?
1992
1992
The ability of dopamine D2, mixed D1/D2 and selective D1 receptor antagonists, including NNC-112, NNC-687, NNC-756, to inhibit… Expand
Is this relevant?
1992
1992
Glucuronidation of the two enantiomeric dopamine D-1 antagonists, NNC 0756 ([(+)-8-chloro-7-hydroxy-5-(2,3-dihydrobenzofuran-7-yl… Expand
Is this relevant?